Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > 13 April Researchers load CAR-T cells with Oncolytic virus

View:

Post by askretka on Apr 13, 2022 11:07pm

13 April Researchers load CAR-T cells with Oncolytic virus

https://www.sciencedaily.com/releases/2022/04/220413141538.htm ---------------------------------- Date:April 13, 2022Source:Mayo ClinicSummary:Researchers have devised an immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors.

308

Comment

Comment by fasttrack5 on Apr 14, 2022 12:20am

Researchers at Mayo Clinic's Center for Individualized Medicine have devised an immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors. The combination approach, published in Science Translational Medicine, involves loading CAR-T cells, which are ...more

222

Comment